We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+4.41%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$42.6B
AUM Growth
+$4.82B
Cap. Flow
+$3.68B
Cap. Flow %
8.65%
Top 10 Hldgs %
12.95%
Holding
2,932
New
107
Increased
1,463
Reduced
1,212
Closed
134

Sector Composition

Rank Sector Weight
1 Technology 12.83%
2 Financials 12.17%
3 Healthcare 10.88%
4 Industrials 10.2%
5 Consumer Discretionary 9.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WERN icon
1426
Werner Enterprises
WERN
$2.24B
$2.81M 0.01%
77,046
-175,522
-69% -$5.57M
FPRX
1427
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$2.81M 0.01%
68,636
-1,007
-1% -$31.6K
RES icon
1428
RPC Inc
RES
$1.24B
$2.8M 0.01%
113,029
-2,703
-2% -$56.2K
PAC icon
1429
Grupo Aeroportuario del Pacifico
PAC
$12.9B
$2.8M 0.01%
27,306
+18,585
+213% +$2.07M
MTGE
1430
DELISTED
MTGE Investment Corp. Common Stock
MTGE
$2.8M 0.01%
144,238
-9,077
-6% -$173K
TU icon
1431
Telus
TU
$14.9B
$2.8M 0.01%
155,608
+7,266
+5% +$130K
EWBC icon
1432
East-West Bancorp
EWBC
$17.9B
$2.79M 0.01%
46,746
-553
-1% -$31.4K
SNY icon
1433
Sanofi
SNY
$103B
$2.79M 0.01%
56,004
+12,987
+30% +$628K
TOO
1434
DELISTED
Teekay Offshore Partners L.P.
TOO
$2.79M 0.01%
1,171,054
+388,352
+50% +$969K
SHO icon
1435
Sunstone Hotel Investors
SHO
$2.19B
$2.77M 0.01%
172,461
-7,017
-4% -$111K
ACOR
1436
DELISTED
Acorda Therapeutics
ACOR
$2.77M 0.01%
976
+108
+12% +$285K
LNW
1437
DELISTED
Light & Wonder
LNW
$2.77M 0.01%
60,348
-1,439
-2% -$50.2K
FTF
1438
Franklin Limited Duration Income Trust
FTF
$231M
$2.76M 0.01%
229,966
+77,861
+51% +$926K
ESPR
1439
DELISTED
Esperion Therapeutics
ESPR
$2.76M 0.01%
55,095
+3,428
+7% +$165K
TTMI icon
1440
TTM Technologies
TTMI
$12B
$2.76M 0.01%
179,258
+17,970
+11% +$280K
CTRE icon
1441
CareTrust REIT
CTRE
$9.91B
$2.75M 0.01%
144,593
+6,085
+4% +$114K
FOXF icon
1442
Fox Factory Holding Corp
FOXF
$755M
$2.75M 0.01%
63,817
+10,107
+19% +$393K
CSGP icon
1443
CoStar Group
CSGP
$11.7B
$2.75M 0.01%
102,570
+70,100
+216% +$1.95M
ANIP icon
1444
ANI Pharmaceuticals
ANIP
$1.8B
$2.75M 0.01%
52,366
-23
-0% -$1.1K
FMX icon
1445
Fomento Económico Mexicano
FMX
$43.6B
$2.74M 0.01%
28,736
-4,727
-14% -$471K
HRC
1446
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$2.74M 0.01%
37,087
+18,046
+95% +$1.39M
APLE icon
1447
Apple Hospitality REIT
APLE
$3.9B
$2.74M 0.01%
145,013
+922
+0.6% +$16.9K
TER icon
1448
Teradyne
TER
$57.6B
$2.74M 0.01%
73,461
-33,584
-31% -$1.16M
FEI
1449
DELISTED
FIRST TRUST MLP AND ENERGY INCOME FUND
FEI
$2.74M 0.01%
179,459
+16,069
+10% +$245K
BFY
1450
DELISTED
BlackRock New York Municipal Income Trust II
BFY
$2.73M 0.01%
176,124
+6,651
+4% +$102K

Similar funds

Guggenheim Capital's Q3 2017 Portfolio in Review

As of Q3 2017, Guggenheim Capital held 2,932 positions worth $42.6B, up 13% from $37.8B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Guggenheim Capital deployed $3.68B of net new capital in Q3 2017, opening 107 new positions and adding to 1,463 existing holdings. Its largest new stake was CLAYMORE US CAPITAL MARKETS MICRO-TERM FIXED INCOME ETF: 1,677,943 shares worth $84.5M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was MALLINCKRODT PUBLIC LIMITED COMPANY, an estimated $46.6M trimmed.

  • Guggenheim Capital's largest Q3 2017 buy was CLAYMORE US CAPITAL MARKETS MICRO-TERM FIXED INCOME ETF: 1,677,943 shares worth $84.5M.
  • Guggenheim Capital added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2017, an estimated $209M increase.
  • Guggenheim Capital's biggest Q3 2017 reduction was MALLINCKRODT PUBLIC LIMITED COMPANY, cutting an estimated $46.6M.
  • Guggenheim Capital fully exited Reynolds American Inc in Q3 2017, selling an estimated $68.3M.
  • Guggenheim Capital's ten largest holdings make up 13% of its $42.6B portfolio in Q3 2017.
  • Guggenheim Capital opened 107 new positions and closed 134 in Q3 2017.
  • Guggenheim Capital's portfolio value rose 13% quarter-over-quarter to $42.6B.

Based on Guggenheim Capital's 13F filing for Q3 2017, filed 14 Nov 2017.